FLAG with Bortezomib in Childhood Relapsed Refractory Leukaemia- A Single Centre Experience

Sreedhar Jayakrishnan, MD^1*, Kesavan MR, MD, FNB (Paediatric Hemato Oncology) ², Gangadharan KV MD, DM(Medical Oncology). ¹, Sreelesh KP MD, DM (Medical Oncology)¹, Arun Chandrashekaran MD, DM (Medical Oncology) ¹, Sudeep Vaniyath MD, DM (Clinical Haematology) ³, Karthika KV MD, DM (Hematopathology)⁴,

¹ Department of Medical Oncology, ASTER MIMS, Kozhikode, India

² Department of Pediatric Hematology and Hemato-Oncology, ASTER MIMS, Kozhikode, India

³ Department of Hematology and Hemato-Oncology, ASTER MIMS, Kozhikode, India

⁴ Department of Pathology, ASTER MIMS, Kozhikode, India

^* Correspondence to:

Sreedhar Jayakrishnan, MD, Department of Medical Oncology, ASTER MIMS, Kozhikode, Kerala, India , 673016

Tel.: +91-8495819063, Email: srj1216353@gmail.com

Running Title- FLAG-Bortezomib in Paediatric relapsed/refractory Leukaemia

Number of Tables- One

Key Words- Haematology, Haemato- Oncology, Relapsed Leukaemia, Toxicity, Hematopoietic Stem Cell Transplant

Word Count-

1280 Words (Main Text)

106 (Abstract)